Snapshot

The Reliance Pathway pathway has been developed by the Dirección General de Medicamentos, Insumos y Drogas (DIGEMID) of Peru.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

$0-1000